000142933 001__ 142933
000142933 005__ 20240229112536.0
000142933 0247_ $$2doi$$a10.1186/s13148-018-0604-y
000142933 0247_ $$2pmid$$apmid:30678711
000142933 0247_ $$2pmc$$apmc:PMC6346508
000142933 0247_ $$2ISSN$$a1868-7075
000142933 0247_ $$2ISSN$$a1868-7083
000142933 0247_ $$2altmetric$$aaltmetric:54672586
000142933 037__ $$aDKFZ-2019-00561
000142933 041__ $$aeng
000142933 082__ $$a610
000142933 1001_ $$0P:(DE-He78)8218df9f6f41792399cd3a29b587e4e7$$aGao, Xin$$b0$$eFirst author
000142933 245__ $$aThe associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study.
000142933 260__ $$a[S.l.]$$bBioMed Central$$c2019
000142933 3367_ $$2DRIVER$$aarticle
000142933 3367_ $$2DataCite$$aOutput Types/Journal article
000142933 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1554361547_31855
000142933 3367_ $$2BibTeX$$aARTICLE
000142933 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000142933 3367_ $$00$$2EndNote$$aJournal Article
000142933 520__ $$aReactive oxygen species may be involved in epigenetic gene activation or silencing. We aimed to identify CpG sites, at which DNA methylation is related to urinary 8-isoprostane levels (biomarker of lipid peroxidation) and cancer or mortality outcomes. This investigation was based on a German, population-based cohort with linkage to cancer and mortality registry data (2000-2016).Blood DNA methylation in promoter regions of 519 genes, known to be involved in pathways from oxidative stress (OS) to cancer, was obtained at the cohort's baseline examination. Inverse associations of DNA methylation at cg25365794 (ALOXE3) and cg08862778 (MTOR) with 8-isoprostane levels were observed in a derivation set (n = 1000) and validated in two independent subsets of the cohort (n = 548 and n = 741). Multivariate regression models were used to evaluate the associations of DNA methylation at the two CpG sites with lung, colorectal, prostate, breast, and overall cancer incidence as well as CVD, cancer, and all-cause mortality. DNA methylation at cg25365794 (ALOXE3) was inversely associated with lung and prostate cancer incidence. DNA methylation at cg08862778 (MTOR) was associated with a 43% lower breast cancer incidence in the top vs. bottom tertile.The finding for ALOXE3 may not be causal. As ALOXE3 is mainly expressed in skin tissue, the observed association might reflect the fact that both DNA methylation at the ALOXE3 gene and urinary 8-isoprostane concentrations depend on the level of OS in tissues. Contrarily, the finding for the MTOR gene and breast cancer is biologically plausible because the MTOR protein plays an important role in PI3K/Akt signaling, which is a pathway related to cancer development and cell senescence.
000142933 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000142933 588__ $$aDataset connected to CrossRef, PubMed,
000142933 7001_ $$0P:(DE-He78)6a8f87626cb610618a60d742677284cd$$aZhang, Yan$$b1
000142933 7001_ $$0P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf$$aBurwinkel, Barbara$$b2
000142933 7001_ $$0P:(DE-He78)ebbb855092f574cef61b6f3ce7640d87$$aXuan, Yang$$b3
000142933 7001_ $$0P:(DE-He78)53e1a2846c69064e27790dbf349ccaec$$aHolleczek, Bernd$$b4
000142933 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5
000142933 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b6$$eLast author
000142933 773__ $$0PERI:(DE-600)2553921-8$$a10.1186/s13148-018-0604-y$$gVol. 11, no. 1, p. 14$$n1$$p14$$tClinical epigenetics$$v11$$x1868-7083$$y2019
000142933 909CO $$ooai:inrepo02.dkfz.de:142933$$pVDB
000142933 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8218df9f6f41792399cd3a29b587e4e7$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000142933 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6a8f87626cb610618a60d742677284cd$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000142933 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000142933 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ebbb855092f574cef61b6f3ce7640d87$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000142933 9101_ $$0I:(DE-HGF)0$$6P:(DE-He78)53e1a2846c69064e27790dbf349ccaec$$aExternal Institute$$b4$$kExtern
000142933 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000142933 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000142933 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000142933 9141_ $$y2019
000142933 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN EPIGENETICS : 2017
000142933 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000142933 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000142933 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000142933 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000142933 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000142933 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000142933 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000142933 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000142933 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000142933 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000142933 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000142933 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000142933 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000142933 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCLIN EPIGENETICS : 2017
000142933 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000142933 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000142933 9201_ $$0I:(DE-He78)C080-20160331$$kC080$$lMolekulare Epidemiologie$$x2
000142933 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x3
000142933 980__ $$ajournal
000142933 980__ $$aVDB
000142933 980__ $$aI:(DE-He78)C070-20160331
000142933 980__ $$aI:(DE-He78)C120-20160331
000142933 980__ $$aI:(DE-He78)C080-20160331
000142933 980__ $$aI:(DE-He78)L101-20160331
000142933 980__ $$aUNRESTRICTED